These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23358467)

  • 1. Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
    Fan S; Müller S; Chen ZG; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun SY
    Cancer Biol Ther; 2013 Apr; 14(4):365-9. PubMed ID: 23358467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact.
    Elrod HA; Fan S; Muller S; Chen GZ; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun SY
    PLoS One; 2010 Aug; 5(8):e12178. PubMed ID: 20808443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FADD the bad in head and neck cancer.
    Dent P
    Cancer Biol Ther; 2013 Sep; 14(9):780-1. PubMed ID: 23974629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
    Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
    Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
    Shen B; Han W; Tan X; Gu KJ; Naseem DF; Zheng G; Li G; Lou J; Chen C
    Mol Carcinog; 2024 Jul; 63(7):1406-1416. PubMed ID: 38695620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
    Eytan DF; Snow GE; Carlson S; Derakhshan A; Saleh A; Schiltz S; Cheng H; Mohan S; Cornelius S; Coupar J; Sowers AL; Hernandez L; Mitchell JB; Annunziata CM; Chen Z; Van Waes C
    Cancer Res; 2016 Sep; 76(18):5442-5454. PubMed ID: 27469115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
    Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
    Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
    Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
    Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
    Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
    Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.
    Li C; Egloff AM; Sen M; Grandis JR; Johnson DE
    Mol Oncol; 2014 Oct; 8(7):1220-30. PubMed ID: 24816188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Lymph Node Metastasis by Tumor Dimension Versus Tumor Biological Properties in Head and Neck Squamous Cell Carcinomas.
    Jang JY; Kim MJ; Ryu G; Choi N; Ko YH; Jeong HS
    Cancer Res Treat; 2016 Jan; 48(1):54-62. PubMed ID: 25761475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
    Xu J; Müller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF; Beitler JJ; Shin DM; Chen ZG
    Eur J Cancer; 2012 Jul; 48(11):1682-91. PubMed ID: 22341992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
    Day TW; Huang S; Safa AR
    Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of Ashwagandha against human head and neck cancer cell lines.
    Lee HE; Shin JA; Jeong JH; Jeon JG; Lee MH; Cho SD
    J Oral Pathol Med; 2016 Mar; 45(3):193-201. PubMed ID: 26332363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
    Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
    Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.
    Yang H; Song Y
    J Mol Model; 2016 Apr; 22(4):89. PubMed ID: 26995783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
    Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
    PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.